Ainos (OTCMKTS:AIMD) Stock Price Down 1.2% – Here’s What Happened

Ainos, Inc. (OTCMKTS:AIMD) fell 1.2% during mid-day trading on Friday . The stock traded as low as $1.62 and last traded at $1.64. Approximately 14,126 shares changed hands during trading, a decline of 99% from the average daily volume of 1,001,429 shares. The stock had previously closed at $1.66.

Ainos Trading Down 1.2%

The firm has a market capitalization of $7.89 million, a price-to-earnings ratio of -1.89 and a beta of 2.50. The firm’s 50-day simple moving average is $1.81 and its 200 day simple moving average is $2.69. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.92 and a quick ratio of 1.45.

Ainos Company Profile

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.